Clinical outcomes and cost-utility analysis of GKRS plus TKIs versus TKIs in patients with EGFR-mutant lung adenocarcinoma and brain metastases: a Markov decision model

医学 脑转移 肿瘤科 肺癌 内科学 恶性肿瘤 外科 转移 癌症
作者
Szu-Hao Andrew Liu,Cheng‐Chia Lee,Huai‐Che Yang,Wei-Lun Huang,Yu‐Hsien Huang,Wen‐Yuh Chung,Hon-Yi Shi
出处
期刊:Journal of Neurosurgery [American Association of Neurological Surgeons]
卷期号:142 (6): 1710-1719 被引量:1
标识
DOI:10.3171/2024.7.jns24310
摘要

OBJECTIVE: This study focuses on epidermal growth factor receptor-mutated lung adenocarcinoma, known for frequent brain metastasis. It aimed to compare the clinical outcomes and cost-effectiveness of combining Gamma Knife radiosurgery (GKRS) with tyrosine kinase inhibitors (TKIs) (GKRS+TKI group) versus TKIs alone (TKI group) for the treatment of patients with newly diagnosed brain metastasis in this condition. METHODS: Study characteristics of the two groups were matched using inverse probability of treatment weighting (IPTW). In the incremental cost-utility ratio (ICUR) model, a healthcare provider perspective, a 1-month cycle length, a 5-year time horizon, and a discount rate of 2% per year for both effectiveness and costs were adopted. Probabilistic and one-way sensitivity analyses were also conducted to demonstrate the robustness of the findings. Statistical analysis was performed using IBM SPSS version 23.0, and cost-effectiveness analysis was conducted using TreeAge Pro software. RESULTS: After applying IPTW, the GKRS+TKI group included 205 patients, and the TKI group consisted of 102 patients, with no statistically significant differences in whole confounders. The GKRS+TKI group demonstrated significantly prolonged median progression-free survival (37.5 months vs 10.6 months, p < 0.001) and median overall survival (55.1 months vs 30.8 months, p < 0.001) compared with the TKI group. The GKRS plus TKI strategy achieved an ICUR of $30,532.25 per quality-adjusted life year relative to the TKIs at the willingness-to-pay threshold of US$33,059 (Taiwan's per capita gross domestic product). CONCLUSIONS: The use of GKRS plus TKIs not only reduces disease recurrence and improves prognosis but also demonstrates a higher level of cost-effectiveness. These findings offer valuable guidelines for clinicians and inform healthcare authorities in optimizing resource allocation for improved medical care.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
搜集达人的应助被灶鲜森采纳,获得10
刚刚
imtutu完成签到,获得积分20
1秒前
w11完成签到,获得积分10
2秒前
白大公子完成签到,获得积分10
2秒前
3秒前
linxi完成签到,获得积分10
4秒前
4秒前
亦依然完成签到 ,获得积分10
4秒前
范范范发布了新的文献求助10
5秒前
5秒前
Yoke完成签到,获得积分10
6秒前
无限的哈密瓜完成签到 ,获得积分20
6秒前
初景的应助被白大公子采纳,获得20
7秒前
7秒前
Vanff发布了新的文献求助10
8秒前
9秒前
木槿昔年完成签到,获得积分10
9秒前
大Lee完成签到,获得积分10
9秒前
888完成签到,获得积分10
10秒前
AlexMoser发布了新的文献求助10
10秒前
YYY完成签到,获得积分10
10秒前
gong发布了新的文献求助10
10秒前
ww完成签到 ,获得积分10
11秒前
迅速的岩完成签到,获得积分10
12秒前
12秒前
12秒前
hyl完成签到,获得积分10
12秒前
灶鲜森发布了新的文献求助10
13秒前
13秒前
大模型的应助被WYL采纳,获得10
13秒前
桐桐的应助被imtutu采纳,获得30
15秒前
heiyi完成签到,获得积分10
15秒前
15秒前
15秒前
Phalaenopsis发布了新的文献求助10
15秒前
白betty完成签到,获得积分10
16秒前
自然若完成签到,获得积分10
16秒前
表弟慢热手完成签到,获得积分10
16秒前
无花果的应助被无私的世界采纳,获得30
17秒前
clock完成签到 ,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190638
求助须知:如何正确求助?哪些是违规求助? 9577731
关于积分的说明 21854501
捐赠科研通 7789728
什么是DOI,文献DOI怎么找? 3436425
关于科研通互助平台的介绍 2560286
邀请新用户注册赠送积分活动 2483144